Antigens, Differentiation, Myelomonocytic
"Antigens, Differentiation, Myelomonocytic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Surface antigens expressed on myeloid cells of the granulocyte-monocyte-histiocyte series during differentiation. Analysis of their reactivity in normal and malignant myelomonocytic cells is useful in identifying and classifying human leukemias and lymphomas.
MeSH Number(s)
D23.050.301.264.900
D23.101.100.900
Concept/Terms
Antigens, Differentiation, Myelomonocytic- Antigens, Differentiation, Myelomonocytic
- Myelomonocytic Differentiation Antigens
- Antigens, Myelomonocytic, Differentiation
- Differentiation Antigens, Myelomonocytic
- Antigens, Myelomonocytic Differentiation
Below are MeSH descriptors whose meaning is more general than "Antigens, Differentiation, Myelomonocytic".
Below are MeSH descriptors whose meaning is more specific than "Antigens, Differentiation, Myelomonocytic".
This graph shows the total number of publications written about "Antigens, Differentiation, Myelomonocytic" by people in Harvard Catalyst Profiles by year, and whether "Antigens, Differentiation, Myelomonocytic" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 3 | 5 | 8 |
| 1994 | 4 | 2 | 6 |
| 1995 | 0 | 1 | 1 |
| 1996 | 1 | 2 | 3 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 5 | 5 |
| 1999 | 0 | 3 | 3 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 2 | 2 |
| 2002 | 1 | 2 | 3 |
| 2003 | 1 | 4 | 5 |
| 2004 | 2 | 5 | 7 |
| 2006 | 0 | 6 | 6 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 5 | 5 |
| 2009 | 0 | 3 | 3 |
| 2010 | 0 | 5 | 5 |
| 2011 | 6 | 1 | 7 |
| 2012 | 2 | 6 | 8 |
| 2013 | 1 | 9 | 10 |
| 2014 | 5 | 6 | 11 |
| 2015 | 2 | 4 | 6 |
| 2016 | 3 | 8 | 11 |
| 2017 | 3 | 3 | 6 |
| 2018 | 5 | 3 | 8 |
| 2019 | 2 | 7 | 9 |
| 2020 | 5 | 4 | 9 |
| 2021 | 1 | 2 | 3 |
Below are the most recent publications written about "Antigens, Differentiation, Myelomonocytic" by people in Profiles.
-
CD16+CD163+ monocytes traffic to sites of inflammation during necrotizing enterocolitis in premature infants. J Exp Med. 2021 09 06; 218(9).
-
Programmed Death Ligand 1 Is Overexpressed in Liver Macrophages in Chronic Liver Diseases, and Its Blockade Improves the Antibacterial Activity Against Infections. Hepatology. 2021 07; 74(1):296-311.
-
Abnormal Levels of Some Biomarkers of Immune Activation Despite Very Early Treatment of Human Immunodeficiency Virus. J Infect Dis. 2021 05 20; 223(9):1621-1630.
-
The association of soluble CD163, a novel biomarker of macrophage activation, with type 2 diabetes mellitus and its underlying physiological disorders: A systematic review. Obes Rev. 2021 09; 22(9):e13257.
-
Thrombospondin-4 mediates hyperglycemia- and TGF-beta-induced inflammation in breast cancer. Int J Cancer. 2021 04 15; 148(8):2010-2022.
-
Lack of RAC1 in macrophages protects against atherosclerosis. PLoS One. 2020; 15(9):e0239284.
-
CD163 deficiency increases foam cell formation and plaque progression in atherosclerotic mice. FASEB J. 2020 11; 34(11):14960-14976.
-
CSF1R inhibition by a small-molecule inhibitor is not microglia specific; affecting hematopoiesis and the function of macrophages. Proc Natl Acad Sci U S A. 2020 09 22; 117(38):23336-23338.
-
Role of CD68 immunohistochemistry in categorizing benign nonmesothelial cell population and refining "atypical" category in serous fluid cytology. Diagn Cytopathol. 2020 Dec; 48(12):1199-1204.
-
Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute-on-chronic liver failure and acute decompensation. J Gastroenterol Hepatol. 2021 Jan; 36(1):240-248.